Literature DB >> 27279060

Common therapeutic strategies for prion and Alzheimer's diseases.

Saioa R Elezgarai, Emiliano Biasini.   

Abstract

A number of unexpected pathophysiological connections linking different neurodegenerative diseases have emerged over the past decade. An example is provided by prion and Alzheimer's diseases. Despite being distinct pathologies, these disorders share several neurotoxic mechanisms, including accumulation of misfolded protein isoforms, stress of the protein synthesis machinery, and activation of a neurotoxic signaling mediated by the cellular prion protein. Here, in addition to reviewing these mechanisms, we will discuss the potential therapeutic interventions for prion and Alzheimer's diseases that are arising from the comprehension of their common neurodegenerative pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27279060     DOI: 10.1515/hsz-2016-0190

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.

Authors:  Nadine S Rösener; Lothar Gremer; Elke Reinartz; Anna König; Oleksandr Brener; Henrike Heise; Wolfgang Hoyer; Philipp Neudecker; Dieter Willbold
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

2.  An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein.

Authors:  Claudia Stincardini; Tania Massignan; Silvia Biggi; Saioa R Elezgarai; Valeria Sangiovanni; Ilaria Vanni; Michael Pancher; Valentina Adami; Jorge Moreno; Matteo Stravalaci; Giulia Maietta; Marco Gobbi; Alessandro Negro; Jesús R Requena; Joaquín Castilla; Romolo Nonno; Emiliano Biasini
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

Review 3.  Pharmacological Agents Targeting the Cellular Prion Protein.

Authors:  Maria Letizia Barreca; Nunzio Iraci; Silvia Biggi; Violetta Cecchetti; Emiliano Biasini
Journal:  Pathogens       Date:  2018-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.